Inventor
KLOSTERMANN STEFAN
DE20 patents
⚠️ This page may combine multiple inventors who share the name “KLOSTERMANN STEFAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
16 patentsUS9914776B2Mar 13, 2018
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE16 citations92
US10611840B2Apr 7, 2020
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE4 citations84
US10611841B2Apr 7, 2020
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE4 citations84
US11117965B2Sep 14, 2021
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE2 citations73
US11192957B2Dec 7, 2021
Antibodies binding to HLA-A2/WT1
HOFFMANN LA ROCHE2 citations72
US10766967B2Sep 8, 2020
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE1 citations62
US12098213B2Sep 24, 2024
Antibodies binding to HLA-A2/WT1
HOFFMANN LA ROCHE0 citations61
US12378315B2Aug 5, 2025
Anti-rabbit CD19 antibodies and methods of use
HOFFMANN LA ROCHE0 citations59
US11987632B2May 21, 2024
Antibodies binding to HLA-A2/MAGE-A4
HOFFMANN LA ROCHE1 citations56
US11981737B2May 14, 2024
Anti-HLA-G antibodies and use thereof
HOFFMANN LA ROCHE0 citations56
US11680110B2Jun 20, 2023
Three-dimensional structure-based humanization method
HOFFMANN LA ROCHE0 citations52
US12577293B2Mar 17, 2026
Method for the expression of polypeptides using modified nucleic acids
HOFFMANN LA ROCHE0 citations50
US10047162B2Aug 14, 2018
Sequence dependent aggregation
HOFFMANN LA ROCHE0 citations50
US9766251B2Sep 19, 2017
Anti-human IgG1 antibody
HOFFMANN LA ROCHE1 citations50
US12157770B2Dec 3, 2024
Anti-HLA-G antibodies and methods of use thereof
HOFFMANN LA ROCHE0 citations48
US10418126B2Sep 17, 2019
Method for improving antibody stability
HOFFMANN LA ROCHE0 citations34